|
Featured
SoCalBio
Member
Center
for
Applied
Technology
Development,
City of
Hope
(Duarte,
California)
Led by
Dr. Larry
Couture (photo
above),
the
Center
for
Applied
Technology
Development
offers
broad
expertise
in
technology
transfer
and
licensing,
biologics
manufacturing,
quality
assurance
and
regulatory
affairs.
It also
fosters
commercial
investment
in the
development
of
inventions
and
discoveries
derived
from
research
at City
of Hope
by
licensing
the
relevant
intellectual
property ... Learn
more
|
|
SoCalBio
Resources
Looking
for an
IP or
business
transaction
lawyer?
|
|
Use SoCalBio-affiliated
Law firms. Click
here to
see
listing |
|
Recommended
Event
|
|
January
16-17,
2009
Marriott Los
Angeles
Airport
Increase
your
visibility
to
prospective
employees
(44% of
the life
science
graduates
in
California
come
from the
CSU!). CSUPERB is
actively
recruiting
industry
mentors
for the
Career
Networking
Session.
Sponsorships
are
still
available.
Please
contact
Susan
Baxter (sbaxter@mail.sdsu.edu)
to find
out how
you can
get
involved... Click
here to
register
online
|
|
Vivarium
Amenities
Available
|
|

|
|
A
Santa
Clarita-based
biotech
company
has a
state
-of-the-art Vivarium that
is not
fully
utilized.
If you
would
like to
access
this
facility
to
conduct
research
at
reasonable
rates,
please
contact
SoCalBio
at
213-236-4890
for more
information."
|
|
Executive
Global
Business
Series:
Doing
Business
In China |
|

|
|
Jan
26-28,
2009
Rady
Center for
Executive
Development,
UC San
Diego
San Diego,
CA
Click
for more
info
In
partnership
with the
School
of
International
Relations
and
Pacific
Studies,
learn
strategies
for
sourcing,
designing
and
marketing
products,
and
investing
in
China.
Experience
a full
traditional
Chinese
dinner
including
etiquette
and
protocol.
This
course
will
teach
you
everything
you need
to know
about
doing
business
in
China.
Regular
Program
Fee:
$2,150.
Early
Bird
Discount
$1,950*
(discount
ends Dec
31)
|
|
Become
a Member
Join well-known
entrepreneur
Alfred
Mann and
other SoCalBio
leaders to
promote
the
biotech
and
device
industries
in the
Greater
Los
Angeles Metro
Area for
job
creation
and
overall
economic
growth.
|
|

|
|
|
| Coming
Soon |
|
SoCalBio
Networking
Forum
in Orange
County
December
18,
2008,
7:00 am
-
9:30 am
UCI
University
Club
(Irvine,
CA)
Making
Every
Innovation
Count:
Monetizing
IP
Assets
Thanks
to our
Sponsors
|
| Webcast |
- Washington
update:
a live
Ernst
&
Young
healthcare
leadership
webcast
on
the new
administration
and
the
future
of
healthcare
Join
Ernst
&
Young
on 10
December (1:00-2:30
p.m.
EST
New
York;
10:00-11:30
a.m.
PST
Los
Angeles)
for an
exciting
discussion
featuring
nationally-known
healthcare
industry
professionals
as
well
as an
audience
of
senior
healthcare
leaders
from
across
the
country.
This
video
webcast
will
come
to you
live
from E&Y's
Washington
D.C.
studio.
It is
free
and
you
can
register
at:
http://webcast.ey.com/
thoughtcenter/default.aspx?
action=preview&pid=1387
|
| Who
Got NIH
SBIR
Grants in
2008? |
In
2008,
144
California-based
companies
won
NIH
SBIR/STTR
grants totaling $67.40 million or 17.3%
of the
total
allocated.
This
places
California
at the
top of
the
list
of
states
receiving
such
funding.
|
| Venture Funding
and the
Credit
Crunch |
- Could
Venture
Capital
Be the
Casualty
of
This
Recession? (Although
written
from
the
perspective
of
Internet
and
technology
sectors,
the
argument
made
here
may
also be
relevant to
some
segments
of the
bioscience
industry)
VC
funding
will
probably
dry up
somewhat
during
the
present
recession,
like
it
usually
does
in bad
times.
But
this
time
the
result
may be
different.
This
time
the
number
of new
startups
may
not
decrease.
And
that
could
be
dangerous
for
VCs.
When
VC
funding
dried
up
after
the
Internet
Bubble,
startups
dried
up
too.
There
were
not a
lot of
new
startups
being
founded
in
2003.
But
startups
aren't
tied
to VC
the
way
they
were
10
years
ago.
It's
now
possible
for
VCs
and
startups
to
diverge.
And if
they
do,
they
may
not
reconverge
once
the
economy
gets
better
... Read
more
Paul
Capital
Healthcare
offers
companies
an
alternative
to debt
or
equity
as a way
to raise
capital
at a
time
when
markets
may be
unwelcoming
to
companies
seeking
cash to
fuel
growth
...Read
more
|
| Profile |
- SoCalBio
Chairman
Alfred
Mann
Los
Angeles
Business
Journal's
Special
Report:
Eight
Over
Eighty
Alfred
Mann
needs no
special
diet nor
impressive
fitness
regimen
to keeps
his
heart
healthy
and
energy
nearly
boundless.
It's
work
that
keeps
his mind
active,
and
that's
what
drives
the
83-year-old
Mann,
who said
he
generally
puts in
longer
hours
now than
when he
founded
his
first
company
more
than a
half-century
ago. An
80-hour
workweek
is not
atypical
for him.
"Too
many
people
whither
away
when
they
retire,"
Mann
said.
"My
problem
probably
is that
I've got
too much
on my
plate"
... Read
more
|
| Pharma
Talk |
- Goldman
Sachs
unveils
plans
for a
new
pharma
research
funding
Goldman is
in talks
to
provide
hundreds
of
millions
of
dollars
of
funding
to a
large
pharmaceutical
company,
in the
first
evidence
of a
new
business
model for
the
sector
that
will see financing
shifted
away
from
funding
companies
and
towards
targeted
co-development
of
specific
medicines.
This
model
therefore
involved
a
different
approach,
creating
a "research
pool"
into
which
pharma
companies
would
place a
range of
experimental
drugs in
a single
therapeutic
area in
early-stage
phase 1
and 2
trials,
where
their
specialists
would
work
alongside
external
experts
including
scientists,
chemists
and
clinical
research
organizations.
The
action
would
help
create
more
flexible,
transparent
and
cheaper
drug
development,
freed
from
large
bureaucracies
and
heavy
overheads.
It would
also
share
the high
risks of
new drug
development
with
outside
partners
... Read
more
Tight
credit
markets
are no
doubt
hindering
corporate
deals,
but the
strong
likelihood
remains
for more
Big
Pharma
buyouts.
With
their
impending
revenue
decline
on the
horizon,
these
large
companies
are
looking
to
emerging
markets
and the
mid-cap
space
for
growth
potential.
Some of
these
pharmaceutical
giants
will
have no
choice
but to
be
acquisitive
...Read
more
The
Philadelphia
Business
Journal reports
that
drug
developers
have a
backlog
of
experimental
drugs
that
need
to be
tested
in
humans,
but
there's
a
shortage
of
participants
willing
to
enroll
in
clinical
trials
... Read
more
Even
in this
economy,
larger
drug
makers
are
planning
to spend
money on
research
and
development,
according
to a
survey
by Ernst
&
Young
LLP. But
many
local
companies
aren't
jumping
on that
bandwagon
.. Read
more
|
|
Company Headline
|
- Allergan
(Irvine):
- Amgen
(Thousand
Oaks):
- Calando
Pharmaceuticals
(Pasadena):
- DxTerity
Diagnostics
(Rancho
Dominguez):
- Edwards
Lifesciences
(Irvine):
- ISTA
Pharmaceuticals
(Irvine):
- MannKind
(Valencia):
|
|
Jobs
Available
|
- Southern
California
Biomedical
Council
- ACRO
Biotech
(Rancho
Cucamonga):
You
may
submit
your
resume
to us
by
email
to hr@acrobiotech.com
or by
fax
(909-466-6892).
- Office
Manager
Requires
a
bachelor's
or
AA
degree,
good
communication
skills,
self-motivated
to
work
in
an
office
environment.
Experiences
in
accounting,
and
advertising/
marketing/sales
are
preferred.
- Marketing
Manager
Requires
a
bachelor's
degree
in
marketing/advertisement
or
biosciences
and
a
minimum
of
1
years'
experience
in
marketing/sales.
Sales
experience
in
diagnostics
or
other
medical
devices
is
preferred.
- Research
Chemist
Requires
a
master's
degree
in
chemistry/biochemistry
re
related
fields
and
a
minimum
of
1
years'
experience
in
biotechnology
research
and
development
environment.
- Pathway
Diagnostics
(Malibu):
- Agensys
(Santa
Monica):
(Click
here
to see
job
description
and
apply)
-
Instrumentation
Technician
III-IV
-
Purification
Development
Associate/Scientist
-
Research
Associate/Senior
Research
Associate
Target
Validation
-
Research
Associate/Senior
Research
Associate:
Target
validation
-
Manager,
Regulatory
Affairs
-
Director/Senior
Director
Translational
Research
-
Research
Associate
II,
Hybridoma
Group
-
Scientist/Senior
Scientist,
Stem
Cell
Biology
-
Research
Scientist
/
Senior
Research
Scientist:
Target
Validation
-
Research
Associate:
Research
Antibody
Production
-
Research
Associate:
Tissue
Analysis
-
Assistant
-
Buffer
Preparation
&
Production
Support
-
Formulation
Development
Associate
-
Senior
Research
Associate:
In
vivo
validation
-
Scientist
-
In
Vivo
Antibody
Development
|
| Do
you know? |
|

http://www.biosurplus.com
SoCalBio
membership
provides
access to
significant
discounts
on
purchases
of
pre-owned lab
equipment
from BioSurplus through
the SoCalBio
Group
Purchasing
Program.
Designed
for small
and
mid-size
firms,
this
program provides
SoCalBio
members with the
following
benefits:
- 5%
annual
credit
or 1%
annual
cash
rebate
on
equipment
purchases
or net
consignment
sales
proceeds
- 10%
discount
on
setup
fees
for e-Quip enabled
services
- 30-day
limited
warranty
on
most
purchased
equipment
- Experienced
customer
service
representatives
offering
knowledgeable
and
reliable
service
|
| About
SoCalBio |
 SoCalBio
membership
links
you to
partners,
contract
manufacturers,
regulatory
and
legal
experts,
and
policy
makers.
The
organization's
programs
help
emerging
biotech
and
medical
device
companies
grow.
Membership
is
affordable
-- as
low as
$500 --
and
offers
access
to
networking
opportunities,
advocacy,
discounts
through
our
group
purchasing
program group
purchasing
program and
other
benefits
you
simply
can't
find
elsewhere
... Join
SoCalBio
|
| Editor: Ahmed
A. Enany
Southern
California
Biomedical
Council
(SoCalBio)
|
|
| |
|